Celea Therapeutics vs Degron Therapeutics
Celea Therapeutics vs Degron Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Celea Therapeutics is on 53/100 and Degron Therapeutics on 62/100.
Where each one leads
Celea Therapeutics
- agent readiness: 39/100 against 27/100
- domain rating: 48/100 against 25/100
- headcount: 83 against 24
- funding raised: $360M against $40.0M
- LinkedIn following: 12,190 against 1,380
Degron Therapeutics
- our overall score: 62/100 against 53/100
At a glance
| Measure | Celea Therapeutics | Degron Therapeutics |
|---|---|---|
| What it is | Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF). | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. |
| Category | Biotechnology, Pharmaceuticals, HealthTech, Biotech | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | Not published | 2020 |
| Headquarters | Boston, USA | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Celea Therapeutics | Degron Therapeutics |
|---|---|---|
| Employees | 83 | 24 |
| Total funding | $360M | $40.0M |
| Latest round | Funding Round | Series A Extension |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 12,190 | 1,380 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Celea Therapeutics | Degron Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 62/100 |
| Traction | 59/100 | Not published |
| Team | Not published | 24/100 |
| Search visibility | 22/100 | 57/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (27/100) |
| Domain ratingLink authority, 0-100 | 48/100 | 25/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Celea Therapeutics | Degron Therapeutics |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Celea Therapeutics vs Degron Therapeutics: common questions
Which is better, Celea Therapeutics or Degron Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Celea Therapeutics and Degron Therapeutics compare on the numbers?
Celea Therapeutics leads on agent readiness (39/100 against 27/100), domain rating (48/100 against 25/100), headcount (83 against 24), funding raised ($360M against $40.0M), LinkedIn following (12,190 against 1,380). Degron Therapeutics leads on our overall score (62/100 against 53/100).
Read the full Celea Therapeutics review and pricing or the Degron Therapeutics review and pricing. You can also browse other Celea Therapeutics alternatives we track.